home.social

#manda — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #manda, aggregated by home.social.

  1. europesays.com/es/?p=468545 ‘El Hormiguero’ (14.7%) manda un día más en el access y ‘La Revuelta’ (12.1% y 10.4%) cumple con su nueva sesión doble #2026 #26 #access #cumple #dia #doble #ElHormiguero #Entertainment #Entretenimiento #ES #España #jueves #LaRevuelta #manda #marzo #nueva #sesion #Spain #TV

  2. europesays.com/it/306038/ Sclerosi multipla, scoperta la causa della malattia. Virus e genetica: il mix che manda le cellule in tilt – Quotidiano Nazionale #causa #cellule #genetica #Health #IT #Italia #Italy #malattia #manda #multipla #Salute #sclerosi #scoperta #tilt #virus

  3. Hành trình 18 tháng bị thâu tóm không hề là một chuyện cổ tích. Quá trình căng thẳng, bắt đầu từ những cuộc gọi tìm hiểu, qua thẩm định kỹ lưỡng đến đàm phán thỏa thuận phức tạp. Mọi thứ đều lâu hơn dự kiến rất nhiều. #Acquisition #Startup #SaaS #MandA #FounderStory #ThâuTóm #KhởiNghiệp #MuaDam #SaaS #CâuChuyệnNhàSángLập

    reddit.com/r/SaaS/comments/1q7

  4. Led by David Ellison and backed by his centibillionaire father, Larry Ellison, #Paramount Skydance submitted a $77.9 billion hostile takeover bid for #WarnerBros Discovery (WBD) on Monday, emerging as the acquisition attempt seemingly favored by Donald Trump.
    The Ellison-led media group positioned itself as an alternative to Netflix’s recently announced $72 billion agreement to acquire Warner Bros.’ film studio and streaming giant HBO. The proposal would leave out CNN and WBD’s less desirable cable channels, which are set to be spun off into a separate company next year.
    The younger Ellison has sought to convince the Trump administration to support his bid for WBD by offering assurances “that if he bought Warner, he’d make sweeping changes to CNN,” the Wall Street Journal reported on Monday. (Since acquiring CBS News over the summer, David Ellison has already made that network far more conservative.) #markets #finance #MandA #entertainment #streaming

  5. ​$11.7B ICFR GAP. Pothole? No. Structural failure.

    ​Novo Nordisk’s manufacturing scale-up strategy is built on a #CriticalRisk: The Catalent acquisition systems are excluded from ICFR oversight.

    ​They solved for supply. They failed on data integrity.

    ​A hostile data strategist targets this control gap.

    ​Find your competitor's fatal flaw: Data-Backed Competitive Insight. $6k.

    #DataGovernance #MAndA #NVO #ShaolinDataScience

  6. ​$11.7B ICFR GAP. Pothole? No. Structural failure.

    ​Novo Nordisk’s manufacturing scale-up strategy is built on a #CriticalRisk: The Catalent acquisition systems are excluded from ICFR oversight.

    ​They solved for supply. They failed on data integrity.

    ​A hostile data strategist targets this control gap.

    ​Find your competitor's fatal flaw: Data-Backed Competitive Insight. $6k.

    #DataGovernance #MAndA #NVO #ShaolinDataScience

  7. Good Read: Buy Perplexity? If it happens, this could be Apple's biggest acquisition in history.

    "Apple’s slow AI start is a strategic crisis. There will never be a better time to use its cash. Spending $30 billion on a legitimate AI player is vastly better than standing still. The market would likely celebrate it, even if it means a smaller buyback. Growth stocks get growth multiples."

    bigtechnology.com/p/why-apple- #Apple #Perplexity #MandA #BigTechnology #Internet #AI #Search #Siri #Google #TechAcquisition #AISearch

  8. Macquarie Asset Management appoints Kim & Chang as legal advisor for DIG Airgas sale, a major M&A deal valued at 4-5 trillion won, signaling accelerated transaction process and attracting interest from global private equity firms.
    #YonhapInfomax #MacquarieAssetManagement #DIGAirgas #KimAndChang #MAndA #IndustrialGas #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

  9. And — oh, here’s an interesting cash windfall — #Texas #Instruments raised about 💥$2.5 billion by selling stock over these five years.

    Wait, what?

    Selling stock, not buying stock? ⁉️

    Selling stock to whom?

    Hold that thought …

    Put it all together and I figure the company generated about $25 billion in truly free cash flow over this 5-year span. ‼️

    What is management going to spend this treasure chest on?

    Well, surely you’re going to spend a healthy amount on #capital #expenditures, right?

    I mean, you took a $5.2 billion depreciation and amortization charge over this time span,
    and we all know that semiconductor manufacturers need to stay on that bleeding edge of technological innovation to keep earnings growing in the future, right?

    Nope.

    Texas Instruments spent $3.3 billion on fixed assets from 2014 through 2018, one-third of that total in 2018.

    Some significant proportion of that was maintenance capex as opposed to growth capex.

    Well, if you didn’t spend your money on property, plant and equipment, then surely you spent a healthy sum in #MandA, right?

    Nope. $1.6 billion over five years. Tuck-in stuff.

    I guess you were paying down debt, then. #Deleveraging up a storm, right?

    Nope. Paid down debt by $500 million a year in 2014, 2015 and 2016, but increased debt by $500 million in 2017 and $1 billion in 2018.

    So it’s #dividends, right? This is where all the cash went?

    Now we’re getting there:
    ⭐️$9.1 billion in dividends over five years. A healthy direct return of capital to shareholders.

    But it’s just a warm-up to the main event:

    $15.4 billion in #buying #back #stock from 2014 through 2018.

    ⭐️Between stock buybacks and dividends, that’s $24.5 billion in cash “returned to shareholders”,

    essentially 100% of the free cash flow generated by the company over the past five years.❗️

    Now here’s the kicker.

    What sort of share-count reduction would you think that this $15.4 billion in buybacks gets you?

    I mean, that is the logic here, that investing $15.4 billion in the company’s own stock is the best possible capital allocation that the company can make.

    I would have guessed that surely
    $15.4 billion would retire anywhere from 20% to 25% of the shares outstanding over this time frame,
    with the stock price ranging from $40 to $100.

    ♦️In truth, Texas Instruments retired only 10% of its outstanding diluted shares with its $15.4 billion investment,
    going from 1.1 billion shares to 990 million shares.

    ⚠️But wait, there’s more.

    From 2014 through 2018, Texas Instruments bought back 228.6 million shares for $15.4 billion.

    That works out to an average ♦️purchase price of $67.37.

    Over that same span, Texas Instruments sold 90.8 million shares to management and board members as they exercised options and restricted stock grants, for a total of $2.5 billion.

    That works out to an average ♦️sale price of $27.51.

    ⚠️The difference in average purchase price and average sale price, multiplied by the number of shares so affected, is $3.6 billion.

    🔥In other words, 40% of Texas Instrument’s stock buybacks over this five-year period
    🧨were used to sterilize stock issuance to senior management and the board of directors, who received $3.6 billion in direct value from these buybacks.👀

    ♦️But wait, there’s more …

    As of Dec. 31, 2018 there were still 40 million shares outstanding in the form of options and restricted stock grants to management and directors,
    at an average weighted exercise price of $55.

    At today’s stock price, that means an additional $2.6 billion in stock-based compensation has already been awarded.

    Well golly, these surely must have been #amazing #managers and directors to warrant that sort of stock-based compensation in addition to their cash compensation.

    This is the performance of Texas Instruments (in white) and the iShares PHLX Semiconductor ETF (in gold) over the same five years.

    Texas Instruments is the fifth-largest position in that ETF and that underlying index, with a 7.1% weight.

    ⚠️For the past five years, Texas Instruments has been nothing more than a tracking stock for a passive semiconductor index.

    🆘And for this privilege, shareholders have rewarded management and directors with
    💰 $6.2 billion in stock, plus a couple of billion in cash compensation.

    ‼️That’s why it’s never been a better time in the history of the world to be a senior manager of a publicly traded company.

    It’s a crying shame, because here’s the thing … the total return on owning Texas Instruments is, in fact, 👉15% higher than the ETF over this five-year span.

    ❇️Because of the dividend.

    Do you want to run your company for cash generation?

    Do you want to return that cash to shareholders?

    Great!

    ➡️ Use a special dividend, not buybacks.

    There, fixed it for you.

    #financialization #Share #buybacks

    epsilontheory.com/yeah-its-sti

  10. Sensor Tower has acquired rival Data.ai to expand its customer base, including brands like Microsoft and Bandai Namco, and enhance its data accuracy and product offerings. #sensortower #dataai #ai #MandA #merger #acquisition #data #accuracy #dataquality

  11. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism

  12. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism

  13. gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, companies have tallied $64 billion in and deals this year. In the last few weeks alone, said it will pay $43 billion for , agreed to acquire for $10.8 billion, and said it will buy for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off

  14. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism

  15. #Biotech #MandA gets off to a 'blistering' start in 2023, as insiders predict surge in deals
    Already, #biopharma companies have tallied $64 billion in #mergers and #acquisitions deals this year. In the last few weeks alone, #Pfizer said it will pay $43 billion for #Seagen, #Merck agreed to acquire #PrometheusBiosciences for $10.8 billion, and #GSK said it will buy #BellusHealth for $2 billion. It’s a “blistering” pace on track for $300 billion by year’s end!!
    endpts.com/biotech-ma-gets-off #capitalism

  16. Watching policy develop at #Twitter as it changes from a public company to a private company is a study in #MBA101 #MAndA type affairs. 🍿🍿🍿🍿